盐酸法舒地尔治疗急性脑梗死临床观察  被引量:2

Treatment of acute cerebral infarction with hydrochloric fasudil

在线阅读下载全文

作  者:潘金保[1] 王东[1] 

机构地区:[1]岳阳市第二人民医院神经内科,湖南岳阳414000

出  处:《中南药学》2009年第1期63-65,共3页Central South Pharmacy

摘  要:目的观察Rho激酶抑制剂盐酸法舒地尔治疗急性脑梗死的临床疗效和安全性。选择我院2007年7月~2008年4月治疗的急性脑梗死患者60例,随机分为治疗组30例,对照组30例,对照组给予常规治疗,治疗组给予盐酸法舒地尔,观察评价2组患者的神经功能缺损程度的恢复情况及日常生活能力评分等。结果治疗组与对照组神经功能缺损程度的恢复及日常生活能力比较差异有显著性(P〈0.05)。结论急性脑梗死发病后48h内用法舒地尔,可有效改善患者神经功能缺损和日常生活能力,且无严重不良反应。Objective To investigate the clinical efficacy and safety of fasudil, a Rho-kinase inhibitor, in the treatment of acute ischemic stroke. Methods A randomized study was designed to evaluate effect of fasudil on acute cerebral infarction, with routine therapy as placebo - control. Sixty patients were chosen from July 2007 to April 2008 and were divided into 2 groups: fasudil group (30 patients) and control group (30 cases). Excellency, efficacy, improvement of neurological function, and activities of daily living were observed. Results In the fasudil group, excellency, efficacy, improvement of neurological function, and activities of daily living were elevated markedly compared with those in the placebo - control group (P〈0.05). Conclusion Fasudil can increase the neurological function and activities of daily living in the therapy of acute cerebral infarction. Fasudil is a safe medicine.

关 键 词:脑梗死 法舒地尔 RHO激酶 神经功能 日常生活能力 

分 类 号:R971[医药卫生—药品] R742[医药卫生—药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象